11 Sep 2020

Over 40% of Investments in Drug Production Made by Technopolis Moscow Residents

Share this
To favorites

In H1 2020, residents and tenants of the Technopolis Moscow Special Economic Zone invested RUR 3+ bn in the development of production including RUR 1.3 bn in the production of drug and medical materials

Since 2006 residents and tenants of the Special Economic Zone have totally invested about RUR 48 bn in the development of high-tech industries.

RELATED MATERIALS

In more detail
26 Oct
Industrial Area in South-West Moscow Will Be Re-Developed
In more detail
23 Oct
Investors Built 50+ Social Facilities in New Moscow in 8 Years
In more detail
22 Oct
Moscow Ranked 8th in Overall Global Cities Innovation Index
Natalya Sergunina on why Moscow does not fear the crisis and what the city’s government is betting on
Merck
Merck Company does not need to be introduced: more than three centuries of presence at the global health care market, life science and high-tech materials developing speak for themselves. CEO of Merck Life Science in Russia and the CIS Heinz Schmidt told in an interview to investmoscow.ru about the company's mission in our country and innovation laboratory work in the capital.
Gen Terra
The Kalibr Technopark in Moscow accommodates the only Russian industrial manufacturer of chemicals for molecular biology. In his interview to the Moscow Investment Portal, Gen Terra director Vladimir Survilo talked about DNA, genome sequencing and plans to conquer the international market.
All topics